Form 4: Leidos Holdings Director Susan M. Stalnecker Reports Stock Option Exercise and Sale

Sentiment:

SEC Form 4 Filing


Director Susan M. Stalnecker exercised stock options and sold shares of Leidos Holdings, Inc. common stock on May 2, 2024.

Summary

  • On May 2, 2024, Susan M. Stalnecker, a director of Leidos Holdings, Inc., exercised stock options to acquire 4,788 shares of common stock at a price of $52.70 per share.
  • Following the exercise, Stalnecker sold 3,014 shares at a weighted average price of $141.9738, with individual sales ranging from $141.94 to $142.01.
  • 1,774 shares were withheld by Leidos to cover the exercise price and associated fees.
  • After these transactions, Stalnecker directly owns 14,748 shares of Leidos Holdings, Inc. common stock.

Sentiment

Score: 5

Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the actions of company directors. It is a standard practice for publicly traded companies and their executives.

Comparison to Industry Standards

  • Form 4 filings are a standard requirement for directors and officers of publicly traded companies in the United States, as mandated by the Securities and Exchange Commission (SEC).
  • Similar filings are made by insiders at companies like Lockheed Martin (LMT), General Dynamics (GD), and Northrop Grumman (NOC), all of which operate in the same industry as Leidos.
  • The details disclosed in this filing, such as the number of shares, transaction prices, and dates, are consistent with the information typically found in Form 4 filings for other companies.

Stakeholder Impact

  • The transaction provides transparency to shareholders regarding insider activity.
  • The sale of shares could exert minor downward pressure on the stock price, but the impact is likely minimal given the relatively small number of shares involved.

Key Dates

DateDescription
05/11/2018Original date exercisable for stock options
05/02/2024Date of stock option exercise and stock sale
05/03/2024Date of signature for the report
05/11/2024Expiration date for stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.